Kinshasa, Congo – The Democratic Republic of Congo’s health ministry announced Friday that more than 16,000 doses of the Ervebo Ebola vaccine arrived at N’djili International Airport. The shipment is part of an anticipated 70,000‑dose delivery from the World Health Organization (WHO) and partner agencies, with additional doses expected early next week.
Outbreak context
The current outbreak is caused by the rare Bundibugyo virus, a strain for which no approved treatment or vaccine exists. Symptoms often resemble malaria, making early detection difficult. While Ervebo is licensed for Ebola, WHO officials say it may offer some protection against the Bundibugyo variant.
Scale of the crisis
As of Friday, the outbreak has confirmed 5,290 cases and recorded 2,516 deaths, a mortality rate exceeding 47%. Transmission is accelerating, and health officials warn that the epidemic could soon surpass the 2014‑2016 West Africa outbreak, which claimed over 11,000 lives. Data from the Africa Centre for Disease Control suggest the spread has not yet peaked and could triple its current rate.
Challenges to containment
Efforts to control the virus are hampered by ongoing armed conflict between government forces and rebel groups that control key towns in the affected region. Attacks on medical personnel and facilities, a mobile labor force, and large numbers of internally displaced persons further complicate response efforts. Additionally, the region lacks critical health infrastructure needed for rapid testing, treatment, and vaccination.
International response
The WHO and its partners have pledged a total of 70,000 vaccine doses, with the first tranche now in Kinshasa. Health officials hope the vaccine will help curb transmission while broader public‑health measures—such as contact tracing, safe burial practices, and community education—are intensified.
Local and international NGOs are also mobilizing resources to support health workers, provide personal protective equipment, and establish treatment centers in hard‑to‑reach areas.
Continued monitoring and rapid deployment of additional vaccine supplies will be essential to prevent the outbreak from becoming the deadliest Ebola crisis in history.
Original reporting: Alexandria, VA News – WTOP News — read the source article.